"VSports在线直播" Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil. Before sharing sensitive information, make sure you’re on a federal government site. VSports app下载.

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely V体育官网. .

. 2013 Jun 1;73(11):3347-55.
doi: 10.1158/0008-5472.CAN-12-3518. Epub 2013 Apr 11.

Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

Marlous Arjaans  1 , Thijs H Oude Munnink, Sjoukje F Oosting, Anton G T Terwisscha van Scheltinga, Jourik A Gietema, Erik T Garbacik, Hetty Timmer-Bosscha, Marjolijn N Lub-de Hooge, Carolina P Schröder, Elisabeth G E de Vries
Affiliations

"VSports手机版" Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake

Marlous Arjaans et al. Cancer Res. .

Abstract

In solid tumors, angiogenesis occurs in the setting of a defective vasculature and impaired lymphatic drainage that is associated with increased vascular permeability and enhanced tumor permeability. These universal aspects of the tumor microenvironment can have a marked influence on intratumoral drug delivery that may often be underappreciated. In this study, we investigated the effect of blood vessel normalization in tumors by the antiangiogenic drug bevacizumab on antibody uptake by tumors. In mouse xenograft models of human ovarian and esophageal cancer (SKOV-3 and OE19), we evaluated antibody uptake in tumors by positron emission tomographic imaging 24 and 144 hours after injection of (89)Zr-trastuzumab (SKOV-3 and OE19), (89)Zr-bevacizumab (SKOV-3), or (89)Zr-IgG (SKOV-3) before or after treatment with bevacizumab. Intratumor distribution was assessed by fluorescence microscopy along with mean vessel density (MVD) and vessel normalization. Notably, bevacizumab treatment decreased tumor uptake and intratumoral accumulation compared with baseline in the tumor models relative to controls. Bevacizumab treatment also reduced MVD in tumors and increased vessel pericyte coverage VSports手机版. These findings are clinically important, suggesting caution in designing combinatorial trials with therapeutic antibodies due to a possible reduction in tumoral accumulation that may be caused by bevacizumab cotreatment. .

PubMed Disclaimer

Comment in (V体育官网)

Publication types

"VSports app下载" MeSH terms